Abstract:Abstract Molecular testing that interrogates cell free DNA (cfDNA) from plasma has significant potential value across the cancer care continuum, including early cancer detection, driver mutation identification, and disease recurrence monitoring. To achieve this potential, liquid biopsy assays must be optimized to address multiple challenges. For one, cfDNA quantity in the blood is highly variable, with different amounts present depending on malignancy and stage of progression. This requires optimization to detect low concentrations of circulating tumor DNA (ctDNA) and to accommodate variable tumor fractions. In addition, minimizing assay costs will improve test accessibility and adoption. To address these issues, Genece Health is optimizing their lung cancer liquid biopsy assay to accommodate minimal cfDNA input into library preparation. Furthermore, Genece is testing algorithms that tolerate reduced read depths from low-pass whole genome sequencing (LP-WGS) while maintaining high performance. The Genece lung cancer liquid biopsy assay profiles fragment end-motif and size (FEMS) and fragment coverage signals using LP-WGS (Illumina) and proprietary machine learning algorithms. This study first tested the frequency of end motifs in pooled ctDNA after modifying library preparation (IDT) to reduce reagent volumes from 1X down to 0.5X, 0.25X, and 0.1X of manufacturer specification. A range of cfDNA input from 0.25 ng to 6 ng was tested with each library preparation volume. In addition, LP-WGS read coverage from 5X to 1X was evaluated to assess impact on end motif frequency and assay sensitivity. Performance characterization was further evaluated with a cohort of 50 clinical lung cancer and 100 healthy donor plasma samples tested at 1X and 0.25X library reagent volume. We observed an expected increase in library complexity at higher cfDNA input and library reagent volume. Assay performance was minimally impacted by variable cfDNA input and library reagent volume. However, reducing sequencing read depth is tolerated down to 1.25X depth before increasing the variability of end motif frequencies. These observations are corroborated in the 150 clinical sample cohort. This data shows that by altering standard library preparation conditions and reducing unique read depth, liquid biopsy assays can accommodate a wider range of cfDNA, while concurrently decreasing overall costs. Citation Format: Michael Salmans, Dasom Kim, Andrew Carson, Mengchi Wang, Byung In Lee, Bryan Leatham. Optimization of a liquid biopsy assay to accommodate low cfDNA samples and increase throughput [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 323.

LiBis: an ultrasensitive alignment augmentation for low-input bisulfite sequencing

A Comprehensive Evaluation of Alignment Software for Reduced Representation Bisulfite Sequencing Data

LABS: linear amplification-based bisulfite sequencing for ultrasensitive cancer detection from cell-free DNA

Evaluating DNA recovery efficiency following bisulphite modification from plasma samples submitted for cell-free DNA methylation analysis

Cell-free DNA methylome profiling by MBD-seq with ultra-low input

A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection

Shortcut barcoding and early pooling for scalable multiplex single-cell reduced-representation CpG methylation sequencing at single nucleotide resolution

DNA Methylome Profiling at Single-Base Resolution Through Bisulfite Sequencing of 5Mc-Immunoprecipitated DNA.

Abstract 2432: Improved liquid biopsy assay performance using sequencing by binding (SBB)

Valibs: A Visual Aligner for Bisulfite Sequences

BitMapperBS: a fast and accurate read aligner for whole-genome bisulfite sequencing

Targeted DNA methylation from cell-free DNA using hybridization probe capture

Single- Cell Bisulfite-Free 5mc and 5hmc Sequencing with High Sensitivity and Scalability

Abstract 5109: Development of cfDNA reference standards for methylation-sequencing tests

Highly Sensitive and Multiplexed Analysis of Cpg Methylation at Single-Base Resolution with Ligation-Based Exponential Amplification

A New Approach to Decode DNA Methylome and Genomic Variants Simultaneously from Double Strand Bisulfite Sequencing.

Generation of Whole-Genome Bisulfite Sequencing Libraries for Comprehensive DNA Methylome Analysis

Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA

Abstract 323: Optimization of a liquid biopsy assay to accommodate low cfDNA samples and increase throughput

High resolution profiling of human exon methylation by liquid hybridization capture-based bisulfite sequencing

[Practical Stability of Whole-Genome Bisulfite Sequencing Using Plasma Cell-Free DNA].